Orelabrutinib Monotherapy in Patients with Relapsed or Refractory Waldenstrom's Macroglobulinemia in a Single-Arm, Multicenter, Open-Label, Phase 2 Study: Long Term Follow-up Results

被引：2

作者：

Cao, Xinxin ^{[1
]}

Jin, Jie ^{[2
]}

Cheng, Fu Cheng ^{[3
]}

Yi, Shuhua ^{[4
]}

Zhao, Weili ^{[5
]}

Sun, Zimin ^{[6
]}

Yang, Wei ^{[7
]}

Li, Dengju ^{[8
]}

Cui, Guohui ^{[9
]}

Hu, Jianda ^{[10
]}

Liu, Ting ^{[11
,12
]}

Song, Yongping ^{[13
]}

Xu, Bing ^{[14
]}

Zhu, Zunmin ^{[15
]}

Xu, Wei ^{[16
]}

Zhang, Mingzhi ^{[17
,18
]}

Li, Sichen ^{[19
]}

Wang, Weige ^{[20
]}

Zhao, Renbin ^{[19
]}

Zhou, Daobin ^{[21
]}

机构：

[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept Hematol, Peking Union Med Coll Hosp, Beijing, Peoples R China

[2] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Hangzhou, Peoples R China

[3] Soochow Univ, Affiliated Hosp 1, Suzhou, Peoples R China

[4] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Expt Hematol, Natl Clin Res Ctr Blood Dis, Haihe Lab Cell Ecosyst,Inst Hematol & Blood Dis H, Tianjin, Peoples R China

[5] Shanghai Jiao Tong Univ, Natl Res Ctr Translat Med, Shanghai Rui Jin Hosp,Shanghai Inst Hematol, State Key Lab Med Genom,Sch Med, Shanghai, Peoples R China

[6] Anhui Prov Hosp, Hefei, Peoples R China

[7] China Med Univ, Dept Hematol, Shengjing Hosp, Shenyang, Peoples R China

[8] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Hematol, Tongji Hosp, Wuhan, Peoples R China

[9] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Wuhan, Peoples R China

[10] Fujian Med Univ, Dept Hematol, Affiliated Hosp 2, Fuzhou, Peoples R China

[11] Sichuan Univ, West China Hosp, Dept Hematol, Chengdu, Peoples R China

[12] Sichuan Univ, West China Hosp, Inst Hematol, Chengdu, Peoples R China

[13] Zhengzhou Univ, Henan Canc Hosp, Dept Hematol, Affiliated Canc Hosp, Zhengzhou, Peoples R China

[14] Xiamen Univ, Affiliated Hosp 1, Xiamen, Peoples R China

[15] Henan Prov Peoples Hosp, Zhengzhou, Peoples R China

[16] Nanjing Med Univ, Jiangsu Prov Hosp, Dept Hematol, Affiliated Hosp 1, Nanjing, Peoples R China

[17] Zhengzhou Univ, Affiliated Hosp 1, Zhengzhou, Peoples R China

[18] Lymphoma Diag & Treatment Ctr Henan Prov, Zhengzhou, Peoples R China

[19] InnoCare Pharma Ltd, Beijing, Peoples R China

[20] InnoCare Pharma Ltd, Shanghai, Peoples R China

[21] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Beijing, Peoples R China

来源：

BLOOD | 2023年 / 142卷

关键词：

D O I：

10.1182/blood-2023-181500

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页数：4

共 50 条

[1] Evaluation of orelabrutinib monotherapy in patients with relapsed or refractory Waldenstrom's macroglobulinemia in a single-arm, multicenter, open-label, phase 2 study
Cao, Xin-Xin
Jin, Jie
Fu, Cheng-Cheng
Yi, Shu-Hua
Zhao, Wei-Li
Sun, Zi-Min
Yang, Wei
Li, Deng-Ju
Cui, Guo-Hui
Hu, Jian-da
Liu, Ting
Song, Yong-Ping
Xu, Bing
Zhu, Zun-Min
Xu, Wei
Zhang, Ming-Zhi
Tian, Ya-Min
Zhang, Bin
Zhao, Ren-Bin
Zhou, Dao-Bin
[J]. ECLINICALMEDICINE, 2022, 52
[2] Orelabrutinib for the treatment of relapsed or refractory MCL: a phase 1/2, open-label, multicenter, single-arm study
Deng, Li-Juan
Zhou, Ke-Shu
Liu, Li-Hong
Zhang, Ming-Zhi
Li, Zhi-Ming
Ji, Chun-Yan
Xu, Wei
Liu, Ting
Xu, Bing
Wang, Xin
Gao, Su-Jun
Zhang, Hui-Lai
Hu, Yu
Li, Yan
Cheng, Ying
Yang, Hai-Yan
Cao, Jun-Ning
Zhu, Zun-Min
Hu, Jian-Da
Zhang, Wei
Jing, Hong-Mei
Ding, Kai-Yang
Zhang, Xiang-Yang
Zhao, Ren -Bin
Zhang, Bin
Tian, Ya -Min
Song, Yong-Ping
Song, Yu-Qin
Zhu, Jun
[J]. BLOOD ADVANCES, 2023, 7 (16) : 4349 - 4357
[3] Results of a phase 2, multicenter, single-arm, open-label study of lenalidomide in pediatric patients with relapsed or refractory acute myeloid leukemia
O'Brien, Maureen M.
Alonzo, Todd A.
Cooper, Todd M.
Levine, John E.
Brown, Patrick A.
Slone, Tamra
August, Keith J.
Benettaib, Bouchra
Biserna, Noha
Poon, Jennifer
Patturajan, Meera
Chen, Nianhang
Simcock, Mathew
Zimmerman, Linda
Kolb, E. Anders
[J]. PEDIATRIC BLOOD & CANCER, 2021, 68 (07)
[4] Everolimus for Relapsed/Refractory Classical Hodgkin Lymphoma: Multicenter, Open-Label, Single-Arm, Phase 2 Study
Johnston, Patrick B.
Pinter-Brown, Lauren
Rogerio, Jaqueline
Warsi, Ghulam
Chau, Quincy
Ramchandren, Radhakrishnan
[J]. BLOOD, 2012, 120 (21)
[5] Long-Term Safety and Efficacy of Orelabrutinib Monotherapy in Chinese Patients with Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter, Open-Label, Phase II Study
Song, Yuqin
Song, Yongping
Liu, Lihong
Zhang, Mingzhi
Li, Zhiming
Ji, Chunyan
Xu, Wei
Liu, Ting
Xu, Bing
Wang, Xin
Gao, Sujun
Zhang, Huilai
Hu, Yu
Li, Yan
Cheng, Ying
Yang, Haiyan
Cao, Junning
Zhu, Zunmin
Hu, Jianda
Zhang, Wei
Jing, Hongmei
Ding, Kaiyang
Lu, Zhengguang
Zhang, Bin
Zhao, Renbin
Xu, Zhixin
Zhu, Jun
[J]. BLOOD, 2020, 136
[6] Acalabrutinib monotherapy in patients with Waldenstrom macroglobulinemia: a single-arm, multicentre, phase 2 study
Owen, Roger G.
McCarthy, Helen
Rule, Simon
D'Sa, Shirley
Thomas, Sheeba K.
Tournilhac, Olivier
Forconi, Francesco
Kersten, Marie Jose
Zinzani, Pier Luigi
Iyengar, Sunil
Kothari, Jaimal
Minnema, Monique C.
Kastritis, Efstathios
Aurran-Schleinitz, Therese
Cheson, Bruce D.
Walter, Harriet
Greenwald, Daniel
Chen, Dih-Yih
Frigault, Melanie M.
Hamdy, Ahmed
Izumi, Raquel
Patel, Priti
Wei, Helen
Lee, Sun Ku
Mittag, Diana
Furman, Richard R.
[J]. LANCET HAEMATOLOGY, 2020, 7 (02): : E112 - E121
[7] Safety and Efficacy of Orelabrutinib Monotherapy in Chinese Patients with Relapsed or Refractory Mantle Cell Lymphoma: A Multicenter, Open-Label, Phase II Study
Song, Yuqin
Song, Yongping
Liu, Lihong
Zhang, Mingzhi
Li, Zhiming
Ji, Chunyan
Xu, Wei
Liu, Ting
Xu, Bing
Wang, Xin
Gao, Sujun
Zhang, Huilai
Hu, Yu
Li, Yan
Cheng, Ying
Yang, Haiyan
Cao, Junning
Zhu, Zunmin
Hu, Jianda
Zhang, Wei
Jing, Hongmei
Ding, Kaiyang
Lu, Zhengguang
Zhang, Bin
Zhao, Renbin
Xu, Zhixin
Zhu, Jun
[J]. BLOOD, 2019, 134
[8] Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study
Xu, Wei
Zhou, Keshu
Wang, Tingyu
Yang, Shenmiao
Liu, Lihong
Hu, Yu
Zhang, Wei
Ding, Kaiyang
Zhou, Jianfeng
Gao, Sujun
Xu, Bing
Zhu, Zunmin
Liu, Ting
Zhang, Huilai
Hu, Jianda
Ji, Chunyan
Wang, Shunqing
Xia, Zhongjun
Wang, Xin
Li, Yan
Song, Yongping
Ma, Shuo
Tang, Xinran
Zhang, Bin
Li, Jianyong
[J]. AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (04) : 571 - 579
[9] Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study
Huang, Huiqiang
Zhu, Jun
Yao, Ming
Kim, Tae Min
Yoon, Dok Hyun
Cho, Seok-Goo
Eom, Hyeon Seok
Lim, Soon Thye
Yeh, Su-peng
Song, Yuqin
Kwong, Yok Lam
Kim, Jin Seok
Jin, Jie
Shi, Yuankai
Kim, HyeJin
Qing, Min
Zhou, Tianyuan
Gao, Grace
Dong, Zongqi
Qi, Ming
Kim, Won Seog
[J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2021, 14 (01)
[10] Daratumumab monotherapy for patients with relapsed or refractory natural killer/T-cell lymphoma, nasal type: an open-label, single-arm, multicenter, phase 2 study
Huiqiang Huang
Jun Zhu
Ming Yao
Tae Min Kim
Dok Hyun Yoon
Seok-Goo Cho
Hyeon Seok Eom
Soon Thye Lim
Su-peng Yeh
Yuqin Song
Yok Lam Kwong
Jin Seok Kim
Jie Jin
Yuankai Shi
HyeJin Kim
Min Qing
Tianyuan Zhou
Grace Gao
Zongqi Dong
Ming Qi
Won Seog Kim
[J]. Journal of Hematology & Oncology, 14

← 1 2 3 4 5 →